戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  and r=0.00, respectively for heart rate and heart rate variability).
2 lipids, fecal SCFAs, blood pressure, or 24-h heart rate variability.
3 ed cardiac autonomic function and changes in heart rate variability.
4 rrelated to an objective measure of emotion, heart rate variability.
5 ained ventricular arrhythmias, and increased heart rate variability.
6 utonomic balance was assessed by determining heart rate variability.
7  of constipation, gastric emptying time, and heart rate variability.
8 ered cue-related insula activity and reduced heart rate variability.
9 lations typically seen in blood pressure and heart rate variability.
10 rence in cardiac conduction, arrhythmias, or heart rate variability.
11 -users of antidepressants, on heart rate and heart rate variability.
12 mbulatory ECG monitoring for arrhythmias and heart rate variability.
13 poor recovery of fear-induced suppression of heart rate variability.
14 cardiac phase, nor individual differences in heart rate variability.
15 tinal fundus photography, and an analysis of heart rate variability.
16 M(10) exposure was inversely associated with heart rate variability.
17 n-invasive endothelial function studies, and heart rate variability.
18 on produced increased heart rate and reduced heart rate variability.
19 phenotypes similar to CNC, including altered heart rate variability.
20 val (995+/-45 to 670+/-35 ms), and abolished heart rate variability.
21 trol mechanisms may contribute to changes in heart rate variability.
22 een measures of intrinsic cognitive load and heart rate variability.
23 arasympathetic nervous system as measured by heart rate variability.
24 d parasympathetic nervous system activity by heart rate variability.
25 een sedation levels in ICU patients based on heart rate variability.
26 ctivity measured by changes in instantaneous heart-rate variability.
27                                              Heart rate variability, a common and easily measured ind
28 , individual differences in autonomic state (heart rate variability, a proxy measure of autonomic bal
29 d relative power of a high frequency band of heart rate variability (adjusted odds ratio, 1.05; p < 0
30 leus predicted the magnitude of reduction in heart rate variability after induction.
31 entricular ejection fraction, lean mass, and heart rate variability (all p < 0.05 vs. control subject
32 ctivation of sgACC/25 reduces vagal tone and heart rate variability, alters cortisol dynamics during
33 ein) modify PM(2.5)-associated reductions in heart rate variability among 23 young male workers (mean
34 ar to aggravate particle-related declines in heart rate variability among workers.
35         Change in the high-frequency band of heart rate variability, an estimate of parasympathetic o
36       Natural pacing of the heart results in heart rate variability, an indicator of good health and
37                  Previous research that used heart rate variability analysis alone to understand chan
38 on 96-hr neurologic outcomes and survival by heart rate variability analysis in a pig model of prolon
39                                              Heart rate variability analysis revealed sympathetic pre
40                        In this study we used heart rate variability analysis to determine the effect
41  vagal modulation by 8-15%, as determined by heart rate variability analysis, and decreased 24-h urin
42       A significant correlation between 4-hr heart rate variability and 96-hr cerebral performance ca
43               Patients with PAF had very low heart rate variability and a prolonged QTc at baseline (
44                                              Heart rate variability and ambient arrhythmia activity w
45 in-13 reduced blood pressure, and normalized heart rate variability and baroreflex sensitivity in TGA
46                   Continuous measurements of heart rate variability and baroreflex sensitivity in the
47             Using continuous measurements of heart rate variability and baroreflex sensitivity we aim
48         Autonomic impairment, as measured by heart rate variability and baroreflex sensitivity, is si
49 us system function was assessed according to heart rate variability and baroreflex sensitivity.
50      Instantaneous (SD1) and long-term (SD2) heart rate variability and circadian rhythm analyzed via
51                                              Heart rate variability and dietary data were obtained be
52                                              Heart rate variability and plasma catecholamine levels w
53 p between cardiac measures (mean heart rate, heart rate variability and QT interval variability) and
54 ormalized QT variance, and coherence between heart rate variability and QT variability have been meas
55 associated with rapid changes in measures of heart rate variability and repolarization.
56                                         Mean heart rate variability and respiratory rate variability
57                Our results suggest that both heart rate variability and respiratory rate variability
58 lows for uncovering a greater restoration of heart rate variability and respiratory rate variability
59 d its interruption on continuously monitored heart rate variability and respiratory rate variability
60   We aim to explore whether sedation reduces heart rate variability and respiratory rate variability
61 ress event (sham clipping) and compared with heart rate variability and salivary cortisol.
62   For the entire sample, SBR correlated with heart rate variability and salivary cortisol.
63     Basal cardiovascular activity, including heart rate variability and sympathovagal balance, which
64 raphy revealed suppressed interictal resting heart-rate variability and episodes of ictal bradycardia
65  decrease in the high-frequency component of heart rate variability, and a 1.2% increase in QT durati
66 related with decreased resting HR, increased heart rate variability, and enhanced sensitivity to the
67                             Using indices of heart rate variability, and high- and low-frequency powe
68 , urinary retention, dilated pupils, reduced heart rate variability, and impaired catecholamine respo
69 heir effects on cholesterol, blood pressure, heart rate variability, and inflammation.
70                    Frequency of arrhythmias, heart rate variability, and markers of cardiac repolariz
71  influence cardiac autonomic tone and reduce heart rate variability, and may increase the risk of car
72  blunted poststress recovery in systolic BP, heart rate variability, and monocyte chemoattractant pro
73 ess autonomic monitors to record heart rate, heart rate variability, and movement in infants and pare
74 ECG-MI, high QRS nondipolar voltage, reduced heart rate variability, and QT prolongation (in the card
75 tions between alpha7 level, vagally mediated heart rate variability as an indirect reflection of CAP
76  PM and the high-frequency (HF) component of heart rate variability as modified by the presence or ab
77 of the hypothalamic-pituitary-adrenal axis), heart rate variability (as a marker of the sympathovagal
78 zations; higher resting heart rate and lower heart rate variability associated with both outcomes.
79                               Inverse PM(10)-heart rate variability associations were strongest for t
80        The normal increase in high-frequency heart rate variability at night was absent or blunted in
81                   There was no difference in heart rate variability between the 1-year and 2-year pos
82  effects of air pollution on blood pressure, heart rate variability, blood lipids, and biomarkers of
83 lation of air pollutants affects heart rate, heart rate variability, blood pressure, vascular tone, b
84               In the CAD patients, LF and HF heart rate variability both correlated with average BFR
85 so prolonged QTc (to 463+/-7 ms) and reduced heart rate variability but did not significantly change
86 y-inventory, observer rating, coefficient of heart rate variability (C_HRV), and salivary cortisol.
87 sure to particulate air pollutants decreases heart rate variability, causes ST-segment depression and
88  tended to result in greater improvements in heart rate variability compared with placebo (p = 0.052)
89  tended to result in greater improvements in heart rate variability compared with sertraline (p = 0.0
90                                              Heart rate variability components were analyzed for the
91                               In the clinic, heart rate variability continues to be a useful tool in
92 icrom in aerodynamic diameter in relation to heart rate variability, controlling for potential confou
93 lated pollutants on systolic blood pressure, heart rate variability, corrected QT interval, low densi
94                           The two indices of heart rate variability correlated with an index of ocula
95 we investigate a possible mechanism by which heart rate variability could protect against cardiac arr
96                   Time- and frequency-domain heart rate variability demonstrated significant decrease
97 lected based on the patient's heart rate and heart rate variability, derived from the patient's ECG.
98                                The preserved heart rate variability during postresuscitation hypother
99 ion syndrome experienced greater increase in heart rate variability during sedation interruption (p <
100  90 minutes after stress, and high-frequency heart rate variability during stress were also assessed.
101 nsula activity significantly correlated with heart rate variability during the task.
102 stiffness, low (LF)- and high (HF)-frequency heart rate variability, ECG monitoring, and the plasma m
103 al variations in the methionine cycle affect heart rate variability either independently or by modify
104 rdiovascular biomarkers included measures of heart rate variability, endothelial function, baroreflex
105 rosclerosis, oxidative stress, inflammation, heart rate variability, energy metabolism, and increased
106  data, consisting of an individual's labeled heart rate variability epochs from the preceding 24 hour
107        All patients underwent Holter ECG and heart rate variability evaluation at baseline and at 3,
108 ess-induced interleukin-6 and high-frequency heart rate variability explained 15.5% and 32.5% of the
109                                        Fetal heart rate variability (FHRV) emerges from influences of
110  of the heart rate ([Formula: see text]) and heart rate variability ([Formula: see text]).
111 ed TEN produced a significant suppression of heart rate variability, galvanic skin conductance, and s
112                 None of the autonomic tests (heart rate variability, heart rate turbulence, barorefle
113 ocardiography measure of PNS (high frequency heart rate variability; HF-HRV).
114 activity [normalized high frequency power of heart rate variability (HFn)] were evaluated using GLM a
115 e levels of interleukin-6 and high-frequency heart rate variability, higher rmPFC stress reactivity w
116 metry), cardiac function (echocardiography), heart rate variability (Holter electrocardiography), bod
117                  We analyzed trajectories of heart rate variability (HRV) 1 h before and after ischem
118                             Heart rate (HR), heart rate variability (HRV) [rMSSD, SD1, HF (ms(2))] an
119 mplexity analysis is derived from non-linear heart rate variability (HRV) analysis and has shown exce
120                                 Conventional heart rate variability (HRV) analysis, and complexity in
121 complexity analysis, derived from non-linear heart rate variability (HRV) analysis, has been proposed
122  equivalent (V(E)/V(O(2))), heart rate (HR), heart rate variability (HRV) and arterial haemoglobin sa
123 nd genetic and environmental correlations of heart rate variability (HRV) and baroreceptor reflex sen
124                                     Although heart rate variability (HRV) and baroreflex sensitivity
125 s late after the Fontan operation, employing heart rate variability (HRV) and baroreflex sensitivity.
126                                              Heart rate variability (HRV) and CAEP were evaluated bef
127 mparing time and frequency domain changes in heart rate variability (HRV) and electrocardiographic re
128 ds for analyzing the interaction between the heart rate variability (HRV) and electroencephalography
129  the effects of VNS on metabolic parameters, heart rate variability (HRV) and LV function in obese-in
130                                              Heart rate variability (HRV) and pulse rate variability
131                 Frequency domain measures of heart rate variability (HRV) are associated with adverse
132 ion sample whether individuals with impaired heart rate variability (HRV) are at increased risk of de
133                               Heart rate and heart rate variability (HRV) are mainly determined by th
134                                              Heart rate variability (HRV) as an indirect autonomic as
135  of cardiac autonomic modulation assessed by heart rate variability (HRV) during 14-month expeditions
136                                    Decreased heart rate variability (HRV) has been associated with fu
137 ic nervous system functioning as measured by heart rate variability (HRV) has been associated with po
138                                      Reduced heart rate variability (HRV) has been suggested as a pos
139 ssed left ventricular function (LVF) and low heart rate variability (HRV) identify patients at risk o
140 based on frequency-domain characteristics of heart rate variability (HRV) in 24-hour Holter recording
141 ined whether temperature was associated with heart rate variability (HRV) in a Boston, Massachusetts,
142 tes </=2.5 microm in diameter (PM(2.5)) with heart rate variability (HRV) in an occupational cohort (
143 MAE) on inhibitory control and resting-state heart rate variability (HRV) in children with Attention-
144                            Thus, we examined heart rate variability (HRV) in healthy (n = 34), dysmen
145            Depression is associated with low heart rate variability (HRV) in patients following myoca
146 ts of effortful swallowing maneuver (ESM) on heart rate variability (HRV) in subjects with neurogenic
147 considered as the in vitro equivalent of the heart rate variability (HRV) in vivo.
148 rdiac autonomic function was evaluated using heart rate variability (HRV) indices, cardiovascular aut
149                                    Decreased heart rate variability (HRV) is a major risk factor for
150                                              Heart rate variability (HRV) is a valid and non-invasive
151 duced cardiac vagal control reflected in low heart rate variability (HRV) is associated with greater
152 omic function that is clinically assessed by heart rate variability (HRV) is involved in tumorigenesi
153  extract features from ECGs including simple heart rate variability (HRV) metrics, commonly used sign
154 icating that the latter adequately contained heart rate variability (HRV) oscillations.
155                                              Heart rate variability (HRV) predicts cardiac death and
156                                              Heart rate variability (HRV) provides indices of autonom
157                                              Heart rate variability (HRV) provides insight into cardi
158 was obtained from power spectral analysis of heart rate variability (HRV) recordings.
159                                     Abnormal heart rate variability (HRV) reflects autonomic dysfunct
160       The correlation of healthy states with heart rate variability (HRV) using time series analyses
161  We measured blood pressure, heart rate, and heart rate variability (HRV) via 3-h continuous electroc
162                                              Heart rate variability (HRV) was examined in 50 patients
163                                Participant's heart rate variability (HRV) was measured, and they rate
164 roduct (RPP) oxygen saturation (SpO(2)), and heart rate variability (HRV) were measured at rest, midp
165                      Five-minute segments of heart rate variability (HRV) were studied using linear r
166                    Five-minute recordings of heart rate variability (HRV) were used to assess cardiac
167 ure, we measured resting heart rate (HR) and heart rate variability (HRV) with electrocardiogram, and
168 influence (cardiorespiratory interaction) on heart rate variability (HRV) with heartbeats increasing
169 uence of disinhibited eating and vagal tone (heart rate variability (HRV)) on hunger and the postpran
170 data exist on the prospective association of heart rate variability (HRV), a marker of autonomic func
171 at trauma exposure are associated with lower heart rate variability (HRV), a measure of autonomic fun
172                                    Decreased heart rate variability (HRV), also a predictor of mortal
173 ter (PM2.5) has been associated with reduced heart rate variability (HRV), an indicator of cardiac au
174 re (DBT), sleeping heart rate (HR), sleeping heart rate variability (HRV), and sleep timing, could be
175  the relationship of a single day measure of heart rate variability (HRV), and the averaged baseline
176 entified eight loci that are associated with heart rate variability (HRV), but candidate genes in the
177 n ANS activity during waking, as measured by heart rate variability (HRV), have been correlated with
178 art rhythm complexity analysis, derived from heart rate variability (HRV), is a powerful tool to quan
179 ervous system (ANS) function, as measured by heart rate variability (HRV), or cortical electroencepha
180 onomic balance with standing, as measured by heart rate variability (HRV), were prospectively associa
181           However, whether low heart rate or heart rate variability (HRV), which are noninvasive meas
182 its substantial variations in time, known as heart rate variability (HRV), which introduces deviation
183 f waveforms, power spectra and variations in heart rate variability (HRV)--all of which are important
184 e circadian variation in heart rate (HR) and heart rate variability (HRV).
185 n a deterministic rhythm due to the inherent heart rate variability (HRV).
186 uld be associated with beneficial changes in heart rate variability (HRV).
187 pathetic stimulation has variable effects on heart rate variability (HRV).
188  change the conventional spectral indices of heart rate variability (HRV).
189 g effects in humans by analyzing astronauts' heart rate variability (HRV).
190  polycyclic aromatic hydrocarbons (PAHs) and heart rate variability (HRV).
191 der men was associated with reduced baseline heart rate variability (HRV, P<0.05); the change in hear
192                        Second, participant's heart-rate variability (HRV) - a marker of parasympathet
193 ink to health outcomes has been reported for heart-rate variability (HRV), a marker of physiological
194                    We tested whether resting heart-rate variability (HRV), a physiological indicator
195 eased cardiovascular mortality and decreased heart-rate variability (HRV).
196 tegrative physiological parameter of resting heart-rate variability (HRV); low resting HRV indicating
197  a technique to test whether intrinsic fetal heart rate variability (iFHRV) exists and we show the ut
198                  We tested whether intrinsic heart rate variability (iHRV), devoid of any external in
199           We measured resting heart rate and heart rate variability in 13,241 adults (45- to 64-years
200  or = 2.5 microm in aerodynamic diameter and heart rate variability in 518 older men from the Normati
201      The authors investigated heart rate and heart rate variability in a large cohort from Brazil, us
202 homeostasis modifies the effect of PM(10) on heart rate variability in a stratified, random sample of
203 latter may be a surrogate marker of abnormal heart rate variability in CAD.
204 tic age acceleration was not associated with heart rate variability in either preterm or term born in
205 availability in the salience network and the heart rate variability in humans.
206 rdial ischaemia and enables the recording of heart rate variability in non-resting conditions.
207  decrease in the high-frequency component of heart rate variability in persons with the wild-type gen
208       PM(2.5) was negatively associated with heart rate variability in subjects with lower intakes, b
209 ement of parasympathetic autonomic function (heart rate variability) in 19 patients with GAD and 21 c
210 ously shown that cardiac uncoupling (reduced heart rate variability) in the first 24 hours of trauma
211 was assessed using noninvasive techniques of heart rate variability; in particular, time domain analy
212 0001) and the ratio of low-to-high frequency heart rate variability increased (0.24; 95% CI: 0.07, 0.
213 93 +/- 10 vs. 96 +/- 10 mmHg, p = 0.025) and heart rate variability increased (high-frequency power:
214                                              Heart rate variability index was < or =20 U in 363 (29.9
215                                            A heart rate variability index, reflecting sympathetic and
216 thetic activation (plasma catecholamines and heart rate variability indexes; all P<0.05).
217  high-frequency band in spectral analysis of heart rate variability indicated a better preserved vaga
218 panied by an increase in peak high frequency heart rate variability, indicating an increase in parasy
219                     They calculated 5-minute heart rate variability indices and used logarithmically
220                                              Heart rate variability indices reduced significantly aft
221 ography, cardiac autonomic reflex tests, and heart rate variability indices were performed in 55 pati
222       Mean values of baroreflex sensitivity, heart rate variability, intracranial pressure, arterial
223 mponents showed that HIV+ men had: (1) lower heart rate variability irrespective of VL status, and (2
224                                    Depressed heart rate variability is a well-established risk factor
225                             A contributor to heart rate variability is respiratory sinus arrhythmia o
226                    Cardiac function, such as heart rate variability, is abnormal in coronary artery d
227 ognostic tool, it is unclear whether reduced heart rate variability itself is proarrhythmic or if it
228 roreflex sensitivity, heart rate turbulence, heart rate variability, left ventricular end-diastolic d
229 6 +/- 0.2 vs. 0.2 +/- 0.1 low/high frequency heart rate variability (LF/HFHRV )] and cardiac arrhythm
230 ensitivity), short-term spectral analysis of heart rate variability (low frequency/high frequency), a
231 ith increased basal heart rate and decreased heart rate variability (markers of low cholinergic/vagus
232 odynamic diameter during the 48 hours before heart rate variability measurement was associated with a
233                                              Heart rate variability measurements and gastric emptying
234  the probability of each sedation level from heart rate variability measures derived from the electro
235                                              Heart rate variability measures remained significantly d
236 omic dysfunction as assessed using overnight heart rate variability measures.
237  parasympathetic function, using time-domain heart rate variability measures.
238                                              Heart rate variability monitoring has also been suggeste
239                                              Heart rate variability monitoring is becoming more commo
240 xic and hypercapnic chemosensitivity (n=38), heart rate variability (n=34), baroreflex sensitivity (n
241 ecordings as the high-frequency component of heart rate variability or as the variability of RR inter
242 mal autonomics (high night heart rate or low heart rate variability), or notable device therapy (low
243 er arterial stiffness (P = 0.005), LF and HF heart rate variability (P = 0.004, P = 0.006), and vWf l
244 tivity, depressed low-frequency component of heart rate variability (P<0.0001) and baroreflex sensiti
245 underlying respiratory activity (P<0.001) or heart-rate variability (P=0.002).
246  point was the change in alpha1, a nonlinear heart rate variability parameter, between baseline and 1
247                      However, the long-phase heart rate variability parameter, very-low-frequency pow
248                             Neither analyzed heart rate variability parameters nor plasma catecholami
249                              After ablation, heart rate variability parameters showed a significant p
250 g heart beat cycle length (6%), next-morning heart rate variability parameters, and ectopic beats thr
251                 There were no differences in heart rate variability parameters.
252         The low-frequency and high-frequency heart rate variability power declined before the arrhyth
253                    Individual differences in heart rate variability predicted magnitude of differenti
254          Increased QTVI because of depressed heart rate variability predicts cardiovascular mortality
255                     Although measurements of heart rate variability provide a valuable prognostic too
256 d peripheral autonomic measures (heart rate, heart rate variability, pupil diameter, electrodermal ac
257                                    Decreased heart rate variability rather than increased QT variabil
258                 Low frequency/high frequency heart rate variability ratio was similarly increased in
259                                              Heart rate variability recovery is impaired in depressed
260 f autonomic activity, we described increased heart rate variability reflecting increased Lfa and to a
261 traffic-related responses on blood pressure, heart rate variability, repolarization, lipids, and infl
262 ntifying stress (cortisol levels, heart rate/heart rate variability) require specialist equipment and
263  mediators of inflammation and reductions in heart rate variability, returning toward baseline levels
264 vation (noradrenaline, rho = 0.26, P = 0.05; heart rate variability, rho = -0.43, P = 0.003), and tre
265 ], p = 0.647) but was associated with higher heart rate variability (SD of normal-to-normal RR interv
266 ferred: signal-averaged electrocardiography; heart rate variability; severe ventricular arrhythmia on
267 ultaneous measurements of pupil dilation and heart-rate variability show that the neurofeedback indee
268 susceptibility to arrhythmias, whereas lower heart rate variability signals a component of autonomic
269  spontaneous heart rate and markedly greater heart rate variability, similar to sick-sinus syndrome i
270 these roles, EHD3-deficient mice demonstrate heart rate variability, sinus pause, and atrioventricula
271 o 10 mg/min IV) while monitoring heart rate, heart rate variability spectra, QT interval, and blood p
272  Electrocardiograms revealed decreased total heart rate variability, stress-induced arrhythmia, and i
273 he asymmetric barrier induced a reduction in heart rate variability, suggesting that this is a more d
274 vary cortisol (hypothalamic pituitary axis), heart rate variability (sympathetic adrenal medullary sy
275  provides a more precise characterization of heart rate variability that can be employed in conjuncti
276  fluctuations in distal body temperature and heart rate variability that consistently anticipate the
277 lone had no significant effect on changes in heart rate variability, the time-domain signal-averaged
278                                              Heart rate variability, though related to heart rate, as
279                                              Heart rate variability (time and frequency domain) and a
280                 A mathematical model allowed heart rate variability to be partitioned into a componen
281 r hrs after resuscitation, mean RR interval, heart rate variability triangular index, and normalized
282 he final 5 min of each bout was analysed for heart rate variability using fast fourier transformation
283                                              Heart rate variability was assessed with the Fourier tra
284                    Time and frequency domain heart rate variability was calculated in 5-min sections
285 velopment of POAF, total hospital costs, and heart rate variability was compared between groups.
286      The baroreflex was reset in the KO, and heart rate variability was decreased.
287                                              Heart rate variability was measured by 24-hour ambulator
288 2.5 mum in aerodynamic diameter (PM(2.5)) on heart rate variability was modified by dietary intakes o
289 art rate and cycle length were constant, and heart rate variability was small under control condition
290 ystem function and sympathovagal balance, by heart rate variability, was closely related to both this
291              Heart rate, blood pressure, and heart rate variability were assessed every 30 min and co
292 ce and low frequency/high frequency ratio of heart rate variability were assessed using ECG and blood
293                                   Markers of heart rate variability were markedly impaired in CRC pat
294                 Frequency domain analyses of heart rate variability were performed automatically ever
295                           Blood pressure and heart rate variability were registered at day 5 post-MI.
296 ity, plasma norepinephrine, epinephrine, and heart rate variability, were measured.
297  function, which were reflected by decreased heart rate variability, were significantly reduced by nN
298 the autonomous nervous system, as indexed by heart-rate variability, were correlated in a complex man
299 ho failed to mount a significant increase in heart rate variability when sedation was stopped.
300 igher interleukin-6 and lower high-frequency heart rate variability with stress.

 
Page Top